Celcuity Inc. (CELC)
NASDAQ: CELC · Real-Time Price · USD
53.35
-2.96 (-5.26%)
At close: Nov 20, 2026, 4:00 PM EST
53.85
+0.50 (0.94%)
After-hours: Nov 20, 2026, 5:08 PM EST
Celcuity Market Cap
Celcuity has a market cap or net worth of $2.62 billion as of November 20, 2026. It is the 5,286th most valuable company in the world and the 1,543rd biggest in the United States. Its market cap has decreased by 39.89% in one year.
Market Cap
2.62B
Enterprise Value
2.73B
1-Year Change
-39.89%
Global Rank
Country Rank
#1,543 United States
Category
ChartMarket Cap Chart
Since September 20, 2017, Celcuity's market cap has increased from $133.90M to $2.62B, an increase of 1,857.35%. That is a compound annual growth rate of 38.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 2.62B | -43.21% |
| Dec 31, 2025 | 4.62B | 849.61% |
| Dec 31, 2024 | 486.00M | 37.83% |
| Dec 29, 2023 | 352.60M | 62.79% |
| Dec 30, 2022 | 216.60M | 10.12% |
| Dec 31, 2021 | 196.70M | 108.59% |
| Dec 31, 2020 | 94.30M | -13.57% |
| Dec 31, 2019 | 109.10M | -55.23% |
| Dec 31, 2018 | 243.70M | 27.52% |
| Dec 29, 2017 | 191.10M | 42.72% |
| Sep 20, 2017 (IPO) | 133.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Acadia Pharmaceuticals | 3.17B |
| Legend Biotech | 3.12B |
| Telix Pharmaceuticals | 3.05B |
| ADMA Biologics | 3.02B |
| Dyne Therapeutics | 3.00B |
| Vericel | 2.95B |
| Denali Therapeutics | 2.89B |
| IDEAYA Biosciences | 2.65B |